0000899243-21-039454.txt : 20211006 0000899243-21-039454.hdr.sgml : 20211006 20211006161518 ACCESSION NUMBER: 0000899243-21-039454 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211004 FILED AS OF DATE: 20211006 DATE AS OF CHANGE: 20211006 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ong Tuyen CENTRAL INDEX KEY: 0001673178 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39438 FILM NUMBER: 211309900 MAIL ADDRESS: STREET 1: C/O PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gemini Therapeutics, Inc. /DE CENTRAL INDEX KEY: 0001816736 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851613057 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 ONE KENDALL SQUARE, 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: (617) 401-4400 MAIL ADDRESS: STREET 1: 300 ONE KENDALL SQUARE, 3RD FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: FS Development Corp. DATE OF NAME CHANGE: 20200702 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-10-04 0 0001816736 Gemini Therapeutics, Inc. /DE GMTX 0001673178 Ong Tuyen C/O GEMINI THERAPEUTICS, INC. 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 1 0 0 0 Stock Option (Right to Buy) 3.80 2021-10-04 4 A 0 17245 0.00 A 2031-10-03 Common Stock 17245 17245 D This option shall vest and become exercisable on the earlier of (a) the one (1)-year anniversary of the Grant Date and (b) the Company's next annual meeting of stockholders, in each case, so long as the Optionee continues to have a Service Relationship with the Company on such date. /s/ Jason Meyenburg, attorney-in-fact 2021-10-06